Kanya Rajangam
2022 - Senti Biosciences
In 2022, Kanya Rajangam earned a total compensation of $840.5K as Head of Research and Development and Chief Medical Officer at Senti Biosciences.
Compensation breakdown
| Bonus | $90,000 |
|---|---|
| Non-Equity Incentive Plan | $96,515 |
| Option Awards | $412,703 |
| Salary | $241,288 |
| Total | $840,506 |
Rajangam received $412.7K in option awards, accounting for 49% of the total pay in 2022.
Rajangam also received $90K in bonus, $96.5K in non-equity incentive plan and $241.3K in salary.
Rankings
In 2022, Kanya Rajangam's compensation ranked 3,395th out of 5,760 executives tracked by ExecPay. In other words, Rajangam earned more than 41.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,395 out of 5,760 | 41st |
Division Manufacturing | 1,923 out of 3,136 | 39th |
Major group Chemicals And Allied Products | 919 out of 1,422 | 35th |
Industry group Drugs | 859 out of 1,323 | 35th |
Industry Biological Products, Except Diagnostic Substances | 207 out of 291 | 29th |
Source: SEC filing on April 28, 2023.
Rajangam's colleagues
We found two more compensation records of executives who worked with Kanya Rajangam at Senti Biosciences in 2022.